• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Model Number H7493926008400
Device Problem Migration or Expulsion of Device (1395)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 08/23/2017
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.(b)(4).
 
Event Description
It was reported that stent migration occurred.The target lesion is located in the right coronary artery (rca).A 4.00 x16 synergy drug-eluting stent was deployed in the distal rca to treat the lesion.The lesion required a shorter stent to be placed more proximal, so a 4.00 x 8 synergy drug-eluting stent was deployed just proximal to the 4.00 x 16mm stent.Upon inflation, everything seemed to be in appropriate position and again a cine shot was taken; however, it was recognized that the 4.00 x 8 stent had migrated proximally by about 15mm.So another 4.00 x16 synergy drug-eluting stent was delivered to cover the distance between the first stent and the second stent; however, upon delivery through the 4.00 x 8mm synergy stent, it caught that stent and pushed it down adjacent to the original 4.00 x 16 synergy stent.The physician then chose to take a high pressure balloon, a 4.5 x 20 apex non-compliant and post dilated both the 4.00 x 16mm and the 4.00 x 8mm synergy stents in those exact positions and that completed the procedure.No further patient complications reported and the patient was safe and sound.
 
Manufacturer Narrative
Device evaluated by mfr.: a synergy ii us mr 4.00 x 8mm stent delivery system (sds) was returned for analysis without a stent.No stent returned.The balloon was reviewed.There was no stent on the balloon and the balloon folds were not present.It appeared that positive pressure was applied to the balloon and a vacuum pulled.No damage was noted to the balloon.A visual and tactile examination of the hypotube found no issues.A visual and tactile examination of shaft polymer extrusion revealed no issues.A visual and microscopic examination found no issues with the tip.No other issues were identified during the product analysis.The most probable root cause was unable to be determined.(b)(4).
 
Event Description
It was reported that stent migration occurred.The target lesion is located in the right coronary artery (rca).A 4.00 x16 synergy drug-eluting stent was deployed in the distal rca to treat the lesion.The lesion required a shorter stent to be placed more proximal, so a 4.00 x 8 synergy drug-eluting stent was deployed just proximal to the 4.00 x 16mm stent.Upon inflation, everything seemed to be in appropriate position and again a cine shot was taken; however, it was recognized that the 4.00 x 8 stent had migrated proximally by about 15mm.So another 4.00 x16 synergy drug-eluting stent was delivered to cover the distance between the first stent and the second stent; however, upon delivery through the 4.00 x 8mm synergy stent, it caught that stent and pushed it down adjacent to the original 4.00 x 16 synergy stent.The physician then chose to take a high pressure balloon, a 4.5 x 20 apex non-compliant and post dilated both the 4.00 x 16mm and the 4.00 x 8mm synergy stents in those exact positions and that completed the procedure.No further patient complications reported and the patient was safe and sound.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM
Type of Device
BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key6878239
MDR Text Key86692467
Report Number2134265-2017-09038
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08714729840015
UDI-Public08714729840015
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/23/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/20/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/10/2017
Device Model NumberH7493926008400
Device Catalogue Number39260-0840
Device Lot Number19836081
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/01/2017
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/03/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/26/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-